Implementing an intravenous insulin protocol in your practice: practical advice to overcome clinical, administrative, and financial barriers

Semin Thorac Cardiovasc Surg. 2006 Winter;18(4):346-58. doi: 10.1053/j.semtcvs.2006.06.004.

Abstract

Diabetes mellitus is the fourth most common comorbid condition among hospitalized patients, and 30% of patients undergoing open-heart surgery have diabetes. The link between hyperglycemia and poor outcome has been well described, and large clinical trials have shown that aggressive control of blood glucose with an insulin infusion can improve these outcomes. The barriers to implementing an insulin infusion protocol are numerous, despite the fact that doing so is paramount to clinical success. Barriers include safety concerns, such as fear of hypoglycemia, insufficient nursing staff to patient ratios, lack of administrative and physician support, various system and procedural issues, and resistance to change. Key steps to overcome the barriers include building support with multidisciplinary champions, involving key staff, educating staff, and administrators of the clinical and economic benefits of improving glycemic control, setting realistic goals, selecting a validated insulin infusion protocol, and internally marketing the success of the protocol.

Publication types

  • Review

MeSH terms

  • Clinical Protocols*
  • Diabetes Mellitus / drug therapy
  • Financial Management, Hospital / economics
  • Financial Management, Hospital / organization & administration
  • Financial Management, Hospital / standards
  • Humans
  • Hypoglycemia / chemically induced
  • Hypoglycemia / prevention & control
  • Hypoglycemic Agents / economics
  • Hypoglycemic Agents / therapeutic use*
  • Infusions, Intravenous / economics
  • Infusions, Intravenous / methods
  • Infusions, Intravenous / standards
  • Insulin / economics*
  • Insulin / therapeutic use*
  • Medical Staff, Hospital / education
  • Oregon
  • Practice Patterns, Physicians' / economics
  • Practice Patterns, Physicians' / organization & administration
  • Practice Patterns, Physicians' / standards
  • United States

Substances

  • Hypoglycemic Agents
  • Insulin